The Journal of Endocrinological Investigation is a well-established, e-only endocrine journal founded in 1978. It is the official journal of the Italian Society of Endocrinology (SIE), established in 1964.
The journal was founded by Aldo Pinchera, Giovanni Faglia, Antonio Liuzzi, Guido Menzinger, Marcella Motta and Giovan Battista Serra. Aldo Pinchera was the first Editor-in-Chief followed by Giovanni Faglia and Ezio Ghigo and by the current Editor-in-Chief Luigi Bartalena.
The Journal of Endocrinological Investigation is an international journal with an international editorial board, covering all fields of endocrinology and metabolism, including neuroendocrinology, thyroid, parathyroids, adrenal glands, andrology, gynecological endocrinology, obesity, diabetes, pediatric and geriatric endocrinology. Both clinical, translational and basic original studies, as well as opinions, commentaries, solicited and unsolicited reviews, clinical practice guidelines and position statements, letters to the Editor are published after being submitted to rigorous peer review.
The Journal of Endocrinological represents an essential reading not only for endocrinologists engaged in endocrinological research but also for those primarily involved in daily clinical practice.
- Luigi Bartalena
- Publishing model
- Hybrid. Open Access options available
- 3.397 (2019)
- Impact factor
- 3.016 (2019)
- Five year impact factor
- 25 days
- Submission to first decision
- 83 days
- Submission to acceptance
- 167,745 (2019)
Basal ganglia calcification in hypoparathyroidism and pseudohypoparathyroidism: local and systemic metabolic mechanisms
Basal and stimulated calcitonin for the diagnosis of medullary thyroid cancer: updated thresholds and safety assessment
Authors (first, second and last of 11)
Authors (first, second and last of 5)
The pandemic COVID-19 is significantly affecting the general population and vulnerable people with endocrine, diabetic, and metabolic disease. We encourage COVID-19-related research submissions regarding research on the relationship between COVID-19 and endocrine disorders as well as on the experience of diabetic and endocrine patients subject to lockdown and social distancing guidelines. We will expedite the publication of accepted manuscripts on these topics, which Springer Nature is making free-to-access for the duration of the WHO Public Health Emergency of International Concern.
Read the Editor-in-Chief's pick on the latest COVID-19 content
As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
Read the ten best articles published in 2019 especially selected by the Editor-in-Chief
Societies, partners and affiliations
About this journal
- Electronic ISSN
- Abstracted and indexed in
- CAB Abstracts
- Chemical Abstracts Service (CAS)
- Current Contents/ Life Sciences
- EBSCO Discovery Service
- Google Scholar
- Institute of Scientific and Technical Information of China
- Japanese Science and Technology Agency (JST)
- Journal Citation Reports/Science Edition
- OCLC WorldCat Discovery Service
- Pathway Studio
- ProQuest Biological Science Database
- ProQuest Central
- ProQuest Natural Science Collection
- ProQuest SciTech Premium Collection
- ProQuest-ExLibris Primo
- ProQuest-ExLibris Summon
- Science Citation Index
- Science Citation Index Expanded (SciSearch)
- Semantic Scholar
- UGC-CARE List (India)